TLR7型
抗原
体液免疫
免疫原性
细胞免疫
佐剂
生物
交叉展示
卵清蛋白
免疫系统
抗原呈递
免疫学
T细胞
细胞生物学
先天免疫系统
Toll样受体
作者
David Scott Wilson,Sachiko Hirosue,Michal M. Raczy,Leonardo Bonilla-Ramírez,Laura Jeanbart,Ruyi Wang,Marcin Kwissa,Jean‐François Franetich,Maria A.S. Broggi,Giacomo Diaceri,Xavier Quaglia-Thermes,Dominique Mazier,Melody A. Swartz,Jeffrey A. Hubbell
出处
期刊:Nature Materials
[Nature Portfolio]
日期:2019-01-03
卷期号:18 (2): 175-185
被引量:232
标识
DOI:10.1038/s41563-018-0256-5
摘要
Fully effective vaccines for complex infections must elicit a diverse repertoire of antibodies (humoral immunity) and CD8+ T-cell responses (cellular immunity). Here, we present a synthetic glyco-adjuvant named p(Man–TLR7), which, when conjugated to antigens, elicits robust humoral and cellular immunity. p(Man–TLR7) is a random copolymer composed of monomers that either target dendritic cells (DCs) via mannose-binding receptors or activate DCs via Toll-like receptor 7 (TLR7). Protein antigens are conjugated to p(Man–TLR7) via a self-immolative linkage that releases chemically unmodified antigen after endocytosis, thus amplifying antigen presentation to T cells. Studies with ovalbumin (OVA)–p(Man–TLR7) conjugates demonstrate that OVA–p(Man–TLR7) generates greater humoral and cellular immunity than OVA conjugated to polymers lacking either mannose targeting or TLR7 ligand. We show significant enhancement of Plasmodium falciparum-derived circumsporozoite protein (CSP)-specific T-cell responses, expansion in the breadth of the αCSP IgG response and increased inhibition of sporozoite invasion into hepatocytes with CSP–p(Man–TLR7) when compared with CSP formulated with MPLA/QS-21-loaded liposomes—the adjuvant used in the most clinically advanced malaria vaccine. We conclude that our antigen–p(Man–TLR7) platform offers a strategy to enhance the immunogenicity of protein subunit vaccines. A vaccine platform has been developed from a polymeric glyco-adjuvant conjugated to an antigen, and is now shown to target dendritic cells via mannose-binding receptors and generate potent cellular and humoral immune response against malaria.
科研通智能强力驱动
Strongly Powered by AbleSci AI